> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Coherus’ Pegfilgrastim Autoinjector
- URL: https://www.fdaweb.com/fda-approves-coherus-pegfilgrastim-autoinjector/
- Published: 2023-03-10T12:00:00.000Z
- Updated: 2026-09-14T18:18:47.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5153958

FDA has approved a Coherus BioSciences BLA for a single-dose, prefilled autoinjector presentation of its Udenyca (pegfilgrastim-cbqv), a biosimilar of Amgen’s Neulasta that is administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia. “The introduction of the autoinjector option for Udenyca, with the ability to be administered at home or in the doctor’s office, will provide increased choice and control for patients and physicians,” Coherus says. Udenyca was originally approved as a prefilled syringe